Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer
Clinical trial NCT04194359 · UNKNOWN
Trial details
- NCT number
- NCT04194359
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-04
- Primary completion
- 2022-11-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.